Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Pompe Disease Therapeutics Market - 2023-2030
... The global Pompe disease therapeutics market is expected to exhibit a CAGR of 4.3% during the forecast period (2023-2030). Pompe disease is an inherited lysosomal condition induced by a lack of the enzyme acid alpha-glucosidase ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
... Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the dyslipidemia market through 2032. Examples of key findings from this report include the following - 2022 base year sales within the dyslipidemia market ... Read More
-
NASH Treatment & Therapeutics Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Prevalence of Non-alcoholic Steatohepatitis (NASH) ... Read More
-
Global Pancreatic Cancer Market - 2023-2030
... Pancreatic Cancer market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The pancreas can develop both malignant and non-cancerous tumors, among other growths. Pancreatic ductal adenocarcinoma, the most prevalent form ... Read More
-
Site Management Organizations Market, 2021-2035
... 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. However, the conduct of such trials is ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include - Disease Landscape Disease Overview Epidemiology Overview Treatment Overview ... Read More
-
Liver Diseases Therapeutics Market, Therapy Type (Anti-Rejection Drugs/Immunosuppressant’s, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, Immunoglobulin’s, Corticosteroids)
... Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Liver is the largest organ of the human body. It helps to digest food, store energy, and remove poisons. There are ... Read More
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
... projected to reach USD 4.5 million by 2028 from USD 2.0 billion in 2023, at a CAGR of 17.5%. The key factors driving the growth of the metagenomic sequencing market are the continuous technological innovations ... Read More
-
Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a condition characterized by inflammation or swelling of the sinuses, has become a notable healthcare challenge, causing discomfort and decreased quality of life for patients. The condition, which often presents symptoms such as nasal congestion, ... Read More
-
Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, Peptide); By Application (Diagnostics, Therapeutics, Research & Developments, Others); By Region, And Segment Forecasts, 2023 - 2032
... expected to reach USD 16.33 billion by 2032, according to a new study by Polaris Market Research. The report “Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, and Peptide); By Application ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Global Hereditary Angioedema Therapeutics Market 2023-2027
... hereditary angioedema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Metabolism Drugs Market Size study & Forecast, by Drug Type (Antidiabetic Drugs, Lipid Lowering Drugs, Anti-Obesity Drugs, Thyroid Hormone Drugs, Others) by Indication (Diabetes, Hyperlipidaemia, Obesity, Hypothyroidism) and Regional Analysis, 2023-2030
... Market is valued approximately at USD 16.10 billion in 2022 and is anticipated to grow with a growth rate of more than 6.50% over the forecast period 2023-2030. A metabolism drug refers to a medication ... Read More
-
Chordoma Disease Therapeutics Market
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Chordoma tumors can press the spine, brain, and nerves as they grow causing ... Read More
-
Asia Gout Disease Treatment Market
... By Country (China, India, Japan, South Korea, Thailand, Indonesia, Singapore, Vietnam, and Rest of Asian Countries) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Gout is a chronic disease characterized by pain and ... Read More
-
Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Afric
... The global drug discovery informatics market is experiencing robust growth due to increased investments in novel research and development initiatives by pharmaceutical companies. A significant portion of time and financial resources is dedicated to drug ... Read More
-
AI in Pathology Market by Component (Software, Scanners), Neural Network (CNN, GAN, RNN), Application (Drug Discovery, Diagnosis, Prognosis, Workflow, Education), End User (Pharma, Biotech, Hospital Labs, Research), & Region - Global Forecast to 2028
... global AI in pathology market is projected to reach USD 49 Million by 2028 from USD 24 Million in 2023, at a high CAGR of 15.6% during the forecast period. The AI in pathology market ... Read More
-
Geographic Atrophy
... MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 9.8 million diagnosed prevalent cases of ASD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The current ASD market is highly genericized, with only two products approved by the FDA. The ASD ... Read More
-
Metabolomics Market - Global Outlook & Forecast 2023-2028
... Safety and Quality Control Metabolomics is becoming an increasingly important tool for food safety and quality control due to its ability to analyze the chemicals produced by organisms as they interact with their environment. Metabolomics ... Read More
-
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028
... size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4 % during the forecast period. Factors such advancement in the field of peptide synthesis, and ... Read More
-
Global Artificial Intelligence in Drug Discovery Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD 1405.5 million in 2022 and is forecast to a readjusted size of USD 8529.3 million by 2029 with a CAGR of 29.4% during review period. The influence of COVID-19 and the Russia-Ukraine ... Read More
-
Global Artificial Intelligence in Drug Discovery Supply, Demand and Key Producers, 2023-2029
... of 29.4% CAGR during the forecast period (2023-2029). The key manufacturers of Artificial Intelligence in Drug Discovery include IBM, Google (Alphabet), Atomwise, Schrodinger, Microsoft, etc. The top five players have a combined market share of ... Read More
-
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
... small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels the demand for innovative small-molecule ... Read More
Research Assistance
